Advertisement

Topics

Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low

05:11 EST 14 Nov 2017 | Labiotech.eu

ProQR is aiming to raise funds for clinical trials on the Nasdaq despite the fact that its stock has been down for a while now. ProQR is a biotech based in Leiden that develops RNA therapies for genetic disorders, with ...

This awesome article Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low

NEXT ARTICLE

More From BioPortfolio on "Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...